# Retinal Fundus Imaging and OCT Imaging for Ocular Detection of ATTR-CM

> **NCT07690436** · — · RECRUITING · sponsor: **AstraZeneca** · enrollment: 500 (estimated)

## Conditions studied

- Transthyretin Amyloid Cardiomyopathy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07690436
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-08
- **Primary completion:** 2027-06-18
- **Final completion:** 2027-06-18
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07690436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07690436, "Retinal Fundus Imaging and OCT Imaging for Ocular Detection of ATTR-CM". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07690436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*